Page 101 - 《中国药房》2024年3期
P. 101

双峰形式存在,未发生展宽或者合并现象,且基线未完                                carbapenem  regimen  in  the  treatment  of  carbapenem-
          全分离,因此根据双峰的总面积进行定量。此外,本实                                resistant  enterobacter  infection:a  systematic  review  and
          验用稳定同位素内标IPM-D4矫正了在测量浓度范围内                              meta-analysis[J]. Chin J Antibiot,2023,48(2):235-241.
          IPM 的峰形变化及与 IPM 共洗脱极性内源性化合物的                       [ 9 ]  赖静,张琪,梁园,等. 双碳青霉烯类抗生素治疗碳青霉
          基质效应。                                                   烯类耐药菌感染的荟萃分析[J]. 中国感染与化疗杂志,
              综上所述,本实验建立了一种可以同时定量临床 3                             2019,19(3):300-305.
                                                                  LAI  J,ZHANG  Q,LIANG  Y,et  al.  Effectiveness  of
          种常用碳青霉烯类抗生素(ETP、IPM、MEM)血药浓度
                                                                  double-carbapenem  therapy  on  carbapenem-resistant
          的 UPLC-MS/MS 法,该方法样品前处理简单,检测时间                          infections:a  meta-analysis[J].  Chin  J  Infect  Chemother,
          短,所需样品量少,可以满足临床上(尤其重症患者)对                               2019,19(3):300-305.
          碳青霉烯类抗生素血药浓度的监测需求。                                 [10]  SORNSUVIT  C,WIENTONG  P,UITRAKUL  S,et  al.
          参考文献                                                    Influence of concentration and temperature on stability of
          [ 1 ]  QI Y J,LIU G X. A UPLC-MS/MS method for simultaneous   imipenem  focused  on  solutions  for  extended  infusion[J].
              determination  of  eight  special-grade  antimicrobials  in      Dose Response,2021,19(4):15593258211059325.
              human  plasma  and  application  in  TDM[J].  J  Pharm   [11]  孔维华,鞠浩爽,王晓雪,等 . HPLC 测定人血浆中亚胺
              Biomed Anal,2022,220:114964.                        培南、美罗培南、帕尼培南、法罗培南浓度[J]. 中国药学
          [ 2 ]  CHIRIAC U,FREY O R,ROEHR A C,et al. Personalized   杂志,2014,49(14):1247-1251.
              β-lactam dosing in patients with coronavirus disease 2019   KONG W H,JU H S,WANG X X,et al. Determination of
              (COVID-19) and pneumonia:a retrospective analysis on   imipenem,meropenem,panipenem,faropenem concentra‐
              pharmacokinetics  and  pharmacokinetic  target  attainment  tions in human plasma by HPLC[J]. Chin Pharm J,2014,
              [J]. Medicine,2021,100(22):e26253.                  49(14):1247-1251.
          [ 3 ]  SCHOENENBERGER-ARNAIZ J A,AHMAD-DIAZ F,     [12]  郭玲,罗雪梅,梁培,等. 高效液相色谱法测定重症患者
              MIRALBES-TORNER M,et al. Usefulness of therapeutic   亚胺培南血药浓度及PK/PD达标率研究[J]. 中国医院药
              drug monitoring of piperacillin and meropenem in routine   学杂志,2017,37(16):1598-1601.
              clinical practice:a prospective cohort study in critically ill   GUO  L,LUO  X  M,LIANG  P,et  al.  Determination  of
              patients[J]. Eur J Hosp Pharm,2020,27(e1):e30-e35.  plasma  imipenem  in  critically  ill  patients  by  HPLC  and
          [ 4 ]  DECOSTERD L A,MERCIER T,TERNON B,et al. Vali‐    research  on  PK/PD  targeted  attainment[J].  Chin  J  Hosp
              dation and clinical application of a multiplex high perfor‐  Pharm,2017,37(16):1598-1601.
              mance  liquid  chromatography-tandem  mass  spectrometry   [13]  王晓雪,陈文清,孔旭东,等. 人血浆中亚胺培南和美罗
              assay  for  the  monitoring  of  plasma  concentrations  of  12   培南的 UPLC-MS/MS 分析方法建立及治疗药物监测
              antibiotics in patients with severe bacterial infections[J]. J   [J]. 中国药学杂志,2018,53(3):218-222.
              Chromatogr  B  Analyt  Technol  Biomed  Life  Sci,2020,  WANG X X,CHEN W Q,KONG X D,et al. Quantifica‐
              1157:122160.                                        tion  of  imipenem  and  meropenem  in  human  plasma  by
          [ 5 ]  BADITOIU L,AXENTE C,LUNGEANU D,et al. Inten‐     UPLC-MS/MS  and  its  application  in  therapeutic  drug
              sive care antibiotic consumption and resistance patterns:a   monitoring[J]. Chin Pharm J,2018,53(3):218-222.
              cross-correlation analysis[J]. Ann Clin Microbiol Antimicrob,  [14]  劳佳 . 7 种常用 β-内酰胺类抗生素与 8 种输液的配伍稳
              2017,16(1):71.                                      定性研究[D]. 沈阳:沈阳药科大学,2008.
          [ 6 ]  MABILAT C,GROS M F,NICOLAU D,et al. Diagnostic   LAO J. Study on the compatibility stability of seven com‐
              and medical needs for therapeutic drug monitoring of anti‐  monly  used  β -lactam  antibiotics  with  eight  transfusions
              biotics[J]. Eur J Clin Microbiol Infect Dis,2020,39(5):  [D].Shenyang:Shenyang Pharmaceutical University,2008.
              791-797.                                       [15]  VERDIER M C,TRIBUT O,TATTEVIN P,et al. Simulta‐
          [ 7 ]  GUILHAUMOU  R,BENABOUD  S,BENNIS  Y,et  al.      neous  determination  of  12  beta-lactam  antibiotics  in  hu‐
              Optimization of the treatment with beta-lactam antibiotics   man  plasma  by  high-performance  liquid  chromatography
              in critically ill patients:guidelines from the French Society   with UV detection:application to therapeutic drug monito-
              of Pharmacology and Therapeutics (Société Française de   ring[J].  Antimicrob  Agents  Chemother,2011,55(10):
              Pharmacologie  et  Thérapeutique-SFPT)  and  the  French   4873-4879.
              Society  of  Anaesthesia  and  Intensive  Care  Medicine   [16]  LEFEUVRE S,BOIS-MAUBLANC J,HOCQUELOUX L,
              (Société  Française  d’Anesthésie  et  Réanimation-SFAR)  et  al.  A  simple  ultra-high-performance  liquid  chromato-
              [J]. Crit Care,2019,23(1):104.                      graphy-high  resolution  mass  spectrometry  assay  for  the
          [ 8 ]  李锐,唐志勇,李胜前,等. 双碳青霉烯类药物治疗耐碳                       simultaneous quantification of 15 antibiotics in plasma[J].
              青霉烯肠杆菌感染的有效性系统评价和 Meta 分析[J].                       J Chromatogr B,2017,1065/1066:50-58.
              中国抗生素杂志,2023,48(2):235-241.                                   (收稿日期:2023-09-21  修回日期:2024-01-03)
              LI  R,TANG  Z  Y,LI  S  Q,et  al.  Efficacy  of  double-                            (编辑:舒安琴)


          中国药房  2024年第35卷第3期                                                 China Pharmacy  2024 Vol. 35  No. 3    · 347 ·
   96   97   98   99   100   101   102   103   104   105   106